The company claims that after three doses, the level of protection against the new variant is similar to that of two doses against the delta variant
pub
AstraZeneca announced Thursday that the third dose of its covid-19 vaccine is effective against the Omicron variant. Reuters.
This announcement was made based on a study conducted by a laboratory at Oxford University, which has not yet been published in a scientific journal, which guarantee After the booster dose, levels of antibodies against Omicron are higher than those of infected people and they are recovering normally from the disease.
pub
The company claims that after the three doses, the level of protection against Omicron is similar to that of the first two doses against the Delta variant.
AstraZeneca also confirms that the study was conducted by researchers independent of those who developed the vaccine with the company.
“It is very encouraging to see that current vaccines have the potential to protect against Omicron after a booster dose. These results support the use of the third dose as part of national vaccination strategies, particularly to reduce the prevalence of worrisome variants, including Omicron,” said John Bell, Professor at Oxford University and one of the participating researchers.
pub
pub
pub
In addition to AstraZeneca, too modern it is in Pfizer He confirmed, by analyzing the preliminary data, that taking a third dose of the respective vaccines increases protection against the Omicron variant. Both companies are developing vaccines similarly. specific for the new variable.
